Small artery structure during antihypertensive therapy is an independent predictor of cardiovascular events in essential hypertension

Journal of Hypertension

Volumn 31, Issue 4, 2013, Pages 791-797

  Buus, Niels H ^a,b   Mathiassen, Ole N ^a,b   Fenger Grøn, Morten ^b   Præstholm, Michael N ^a,b   Sihm, Inger ^a   Thybo, Niels K ^b   Schroeder, Anne P ^c   Thygesen, Kristian ^a   Aalkjær, Christian ^b   Pedersen, Ole L ^c   Mulvany, Michael J ^b   Christensen, Kent L ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c VIBORG HOSPITAL   (Denmark)

Author keywords

cardiovascular events; hypertension; resistance artery; structure; treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIA TO LUMEN RATIO; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN BIOPSY; SMALL ARTERY STRUCTURE; SYSTOLIC BLOOD PRESSURE;

EID: 84875214739     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835e215e     Document Type: Article

References (30)

1. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation: contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61:181-186.
2. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 1993; 21:391-397.
3. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001; 19:921-930.
4. Savoia C, Grassi G. The key role of microvascular structure assessment in treated hypertensive patients. J Hypertens 2012; 30:688-690.
5. Rizzoni D, Porteri E, Boari GE, De CC, Sleiman I, Muiesan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108:2230-2235.
6. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007; 25:1021- 1026.
7. De CC, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GE, et al. Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens 2007; 20:846-852.
8. Savoia C, Touyz RM, Endemann DH, Pu Q, Ko EA, De CC, et al. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Hypertension 2006; 48:271-277.
9. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with noninsulin-dependent diabetes mellitus. Circulation 2001; 103:1238-1244.
10. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345- 352.
11. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113:664- 670.
12. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146:483-494.
13. Sihm I, Schroeder AP, Aalkjaer C, Holm M, Morn B, Mulvany M, et al. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril. Blood Press 1995; 4:241-248.
14. Sihm I, Schroeder AP, Aalkjaer C, Mulvany MJ, Thygesen K, Lederballe O. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide- based regimens. Am J Hypertens 1998; 11:263- 271.
15. Morn B. Cardiovascular structure and insulin resistance in essential hypertension. PhD Thesis; Aarhus University, Denmark. 1997.
16. Buus NH, Bottcher M, Jorgensen CG, Christensen KL, Thygesen K, Nielsen TT, et al. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Hypertension 2004; 44:465- 470.
17. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
18. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
19. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003.
20. Eftekhari A, Mathiassen ON, Buus NH, Gotzsche O, Mulvany MJ, Christensen KL. Disproportionally impaired microvascular structure in essential hypertension. J Hypertens 2011; 29:896-905.
21. Christensen KL, Buus NH. Dissociation of blood pressure and resistance artery structure: potential clinical implications. Basic Clin Pharmacol Toxicol 2012; 110:73-79.
22. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827- 838.
23. Pedersen OL, Mancia G, Pickering T, Hoegholm A, Julius S, Kjeldsen SE, et al. Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy. J Hypertens 2007; 25:707-712.
24. Mathiassen ON, Buus NH, Larsen ML, Mulvany MJ, Christensen KL. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens 2007; 25:1027-1034.
25. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23:83-91.
26. Mathiassen ON, Buus NH, Olsen HW, Larsen ML, Mulvany MJ, Christensen KL. Forearm plethysmography in the assessment of vascular tone and resistance vasculature design: new methodological insights. Acta Physiol (Oxf) 2006; 188:91-101.
27. Rizzoni D, Porteri E, Duse S, De CC, Rosei CA, La BE, et al. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry. J Hypertens 2012; 30:1169-1175
28. Britten MB, Zeiher AM, Schachinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 2004; 15:259-264.
29. Palombo C, Kozakova M, Magagna A, Bigalli G, Morizzo C, Ghiadoni L, et al. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens 2000; 18:453-459.
30. Struijker-Boudier HA, Rosei AE, Bruneval P, Camici PG, Christ F, Henrion D, et al. Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J 2007; 28:2834- 2840.